Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Pregnant female urologists should avoid certain drugs and use protective measures to stay safe.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

MK-5108 is safe and shows potential against tumors, especially alone.

GI197111X is best dissolved in Capmul MCM for trials.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The hair treatment materials are safe to use.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Microextraction techniques improve hormone testing while being environmentally friendly.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

A man was poisoned with thallium, treated successfully, but still had some nerve issues after 6 months.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Ca 45 mainly enters rat skin and eye through biosynthesis and may be adsorbed in cartilage and glands.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

Topical thyroid hormones may boost hair growth.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Hydrogels show promise in preventing and treating skin damage from radiation therapy.

Thyroid hormone receptor β1 is found in human hair follicles and helps them survive.

Early diagnosis and treatment of iodine deficiency in buffalo calves is crucial for their healthy growth.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.